Thermo Fisher to acquire PPD for $17.4B

By The Science Advisory Board staff writers

April 15, 2021 -- Thermo Fisher Scientific announced it will acquire clinical research services company PPD for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt.

PPD has more than 26,000 colleagues operating in nearly 50 countries. In 2020, the company generated revenue of $4.7 billion. Upon close of the transaction, PPD will become part of Thermo Fisher's Laboratory Products and Services Segment.

The transaction is expected to be completed by the end of 2021, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals.

Thermo Fisher debuts KingFisher Apex sample purification system
Thermo Fisher Scientific launched its new KingFisher Apex Purification System, a high-throughput sample purification instrument designed to automate the...
Thermo Fisher optimizes mass spec software, launches new Gibco media
Thermo Fisher Scientific announced that it plans to collaborate with Protein Metrics on mass spectrometry data analysis for biopharmaceutical and proteomics...
Thermo Fisher to spend $600M to up bioprocessing production
Thermo Fisher Scientific plans to invest up to $600 million to expand its bioprocessing production capabilities through 2022.

Copyright © 2021 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter